Patents by Inventor Jiali Li

Jiali Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240408097
    Abstract: Disclosed herein is a method of determining subject sensitivity to a WEE1 inhibitor, comprising obtaining or having obtained a biological sample from the subject, and performing or having performed at least one assay on the biological sample to determine if the subject has an altered function of CCNE1. Also disclosed are methods of treating cancer with a WEE1 inhibitor, comprising identifying a subject having (a) the cancer and (b) endogenous or altered function of CCNE1; and administering an effective amount of the WEE1 inhibitor, or a pharmaceutically acceptable salt thereof, to the subject.
    Type: Application
    Filed: December 19, 2023
    Publication date: December 12, 2024
    Inventors: Ahmed Abdi Samatar, Fernando Donate, Petrus Rudolf de Jong, Laure Escoubet, Wen Liu, Philippe Pultar, Dimitrios Voliotis, Kevin Duane Bunker, Peter Qinhua Huang, Jiali Li
  • Publication number: 20240325397
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer.
    Type: Application
    Filed: June 14, 2024
    Publication date: October 3, 2024
    Inventors: Ahmed Abdi Samatar, Fernando Donate, Jiali Li, Jianhui Ma, Kevin Duane Bunker, Peter Qinhua Huang
  • Publication number: 20240270781
    Abstract: Provided in the present disclosure is a preparation method of paeoniflorin-6?-O-benzene sulfonate. The method uses crude paeoniflorin instead of paeoniflorin as a raw material, which more complies with actual requirements of an industrial production process of paeoniflorin-6?-O-benzene sulfonate, and uses an organometallic catalyst, an acid-binding agent and chemically active benzenesulfonyl chloride to react with paeoniflorin. Compared with the prior art, the method significantly increases the yield of crude paeoniflorin-6?-O-benzene sulfonate which is separated and purified by means of column chromatography and then refined to obtain paeoniflorin-6?-O-benzenesulfonate with a content of at least 98%, thereby realizing industrial production of the paeoniflorin-6?-O-benzene sulfonate.
    Type: Application
    Filed: October 19, 2021
    Publication date: August 15, 2024
    Inventors: Wendong XU, Cheng YUAN, Shunzhi TANG, Juyan LIU, Hongfei CAI, Bai BAI, Jing LI, Yuping FU, Songtao LI, Wancai PENG, Yonghua LI, Yao LI, Jirong LI, Shaoheng WEI, Jiali LI
  • Publication number: 20240267675
    Abstract: Disclosed are a signal filtering method and apparatus, a storage medium, and an electronic device. The signal filtering method may include: performing a Fourier transform on time-domain data acquired by M microphones to convert the time-domain data into frequency-domain signals of M channels of a current frame, M is a natural number greater than 1; separating the frequency-domain signals of the M channels to obtain a target signal and an interference signal of the current frame; determining a signal-to-interference ratio between a smooth energy of the target signal and a smooth energy of the interference signal; determining a threshold for the current frame based on the target signal and the interference signal; and filtering the target signal based on the threshold for the current frame and the signal-to-interference ratio between the smooth energies to obtain a pure target signal.
    Type: Application
    Filed: March 24, 2022
    Publication date: August 8, 2024
    Inventors: Jiali LI, Ke PENG, Huaming CHEN, Yannan SUN, Chunhua QIN
  • Publication number: 20230210854
    Abstract: Disclosed herein are compounds and combinations of compounds for treating a disease or condition, such as cancer.
    Type: Application
    Filed: May 12, 2021
    Publication date: July 6, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate, Brant Clayton Boren
  • Publication number: 20230087941
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Peter Qinhua Huang, Sayee Gajanan Hegde, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230068370
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor, and a SERD or SERM inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 2, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Peter Qinhua Huang, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230054767
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a Bcl-2 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Hooman Izadi, Peter Qinhua Huang, Sayee Gajanan Hegde, Joseph Robert Pinchman, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230053946
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and another inhibitor (such as a CDK4/6 inhibitor, a selective aromatase inhibitor, a non-selective aromatase inhibitor, a mTOR inhibitor, a PI3K inhibitor, an ERK or a MEK inhibitor, AKT inhibitor, a BET inhibitor and an Aurora inhibitor), along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Peter Qinhua Huang, Sayee Gajanan Hegde, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230054854
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a Bcl-2 inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Hooman Izadi, Peter Qinhua Huang, Joseph Robert Pinchman, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230042653
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 9, 2023
    Inventors: Ahmed Abdi Samatar, Jianhui Ma, Jiali Li, Peter Qinhua Huang, Sayee Gajanan Hegde, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230008362
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor and a Bcl-2 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: January 12, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Hooman Izadi, Peter Qinhua Huang, Brant Clayton Boren, Joseph Robert Pinchman, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20220125769
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Patent number: 11278532
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: March 22, 2022
    Assignee: Recurium IP Holdings, LLC
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20210038573
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Application
    Filed: August 4, 2020
    Publication date: February 11, 2021
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Patent number: 10652532
    Abstract: System and methods of managing reference frame adaptively for video communication under a network are provided. The system adaptively decides the interval between each I frame, the bitrate of the encoded bit steams, and the resolution of the encoded video to achieve quick connection. The system may set the appropriate reference frame(s) for the current frame, manage the reference frame(s) in the DPB to be long/short term reference frame(s) or mark them as unused for reference; mark the current frame to be a long term reference frame, a short term reference frame, unused for reference or skip encoding the current frame; adaptively change the ratio of long term reference frame(s) with respect to the short term reference frame(s) in the DPB; adaptively change the frequency ratio of marking the current frame as long term reference frame and marking the current frame as short term reference frame.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: May 12, 2020
    Assignee: Agora Lab, Inc.
    Inventors: Wei Dai, Zesen Zhuang, Jian Lou, Qianzong Chen, Jiali Li
  • Patent number: 10630994
    Abstract: A decoding method includes: decoding from the video bitstream a prediction status parameter indicative of whether SOP is enabled; if the SOP is enabled, determining a SOP type indicative of a specific operation for predicting a current picture of the video bitstream; and determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom. An encoding method includes: if SOP is enabled, determining SOP data indicative of a specific operation for predicting a current picture of a video sequence; determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom; and encoding the SOP data.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 21, 2020
    Assignee: Agora Lab, Inc.
    Inventors: Jiali Li, Jian Lou, Zhenyong Chen, Zhonghou Zheng, Wei Dai, Qianzong Chen
  • Publication number: 20190122546
    Abstract: Embodiments of the disclosure provide methods and systems for adjusting road conditions. The system includes a communication interface configured to receive driving information indicative of vehicle driving records on a road. The road includes first and second direction lanes. The system includes a storage configured to store preset parameters. The system includes a processor configured to divide the road into road segments and determine a first traffic congestion index and a second traffic congestion index for the first direction lane and the second direction lane, respectively, based on the driving information associated with each road segment and the preset parameters. The processor is configured to determine a directional imbalance index for the road based on the first and second traffic congestion indices. The processor is configured to provide an instruction to adjust the first direction lane and/or the second direction lane of the road based on the directional imbalance index.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 25, 2019
    Applicant: BEIJING DIDI INFINITY TECHNOLOGY AND DEVELOPMENT CO., LTD.
    Inventors: Dong LU, Jiali LI
  • Publication number: 20190007687
    Abstract: A decoding method includes: decoding from the video bitstream a prediction status parameter indicative of whether SOP is enabled; if the SOP is enabled, determining a SOP type indicative of a specific operation for predicting a current picture of the video bitstream; and determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom. An encoding method includes: if SOP is enabled, determining SOP data indicative of a specific operation for predicting a current picture of a video sequence; determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom; and encoding the SOP data.
    Type: Application
    Filed: June 28, 2017
    Publication date: January 3, 2019
    Inventors: Jiali Li, Jian Lou, Zhenyong Chen, Zhonghou Zheng, Wei Dai, Qianzong Chen
  • Patent number: 10037670
    Abstract: Systems and methods of a safety belt to be worn by individuals in the course of physical activities such as walking, running, biking, etc. Safety belts of the inventive subject matter include one or more sensors that are used to develop a kinematic status of the individual wearing the safety belt. Kinematic status information can be broadcast out wirelessly, and it can be used to determine whether to generate an alert. Some embodiments of the safety belt can detect the presence of a hazard in the vicinity of an individual wearing the safety belt.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: July 31, 2018
    Inventors: Michelle Jing Lin, Eric Xin Lin, Haitao Lin, Jiali Li